Veru Inc Net debt/EBITDA
Cos'è Net debt/EBITDA di Veru Inc?
Net debt/EBITDA di Veru Inc è 2.38
Qual è la definizione di Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA di aziende nel Health Care settore su NASDAQ rispetto a Veru Inc
Cosa fa Veru Inc?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
Aziende con net debt/ebitda simili a Veru Inc
- Schultze Special Purpose Acquisition Corp II ha Net debt/EBITDA di 2.37
- KLA ha Net debt/EBITDA di 2.37
- Infineon Technologies AG ha Net debt/EBITDA di 2.37
- RedFlow ha Net debt/EBITDA di 2.37
- DFS Furniture plc ha Net debt/EBITDA di 2.37
- Abbott Laboratories ha Net debt/EBITDA di 2.37
- Veru Inc ha Net debt/EBITDA di 2.38
- Theriva Biologics Inc ha Net debt/EBITDA di 2.38
- Iwatani ha Net debt/EBITDA di 2.38
- Rotala PLC ha Net debt/EBITDA di 2.38
- Ollies Bargain Outlet Inc ha Net debt/EBITDA di 2.38
- Montero Mining and Exploration ha Net debt/EBITDA di 2.38
- E2 Metals ha Net debt/EBITDA di 2.38